Factor VIII Antihemophilic Globulin^[*)]

Summary

After an historical introduction the author reviews to properties of Factor VIII, its origin and metabolism, methods for its isolation and determination, its rôle in hemostasis and its therapeutic use in cases of hemophilia A and vascular hemophilia A.

^*) Synonyms: (In accordance with the International Committee for Standardization of Nomenclature of the Blood Clotting Factors). Factor VIII (Koller)

^*) Antihemophilic Globulin ( Patek and Taylor)

^*) Antihemophilic Globulin A (Cramer)

^*) A. H. F. Antihemophilic Factor (Brinkhous)

^*) P. T. F. Plasma Thromboplastic Factor (Ratnoff)

^*) P. T. F. A. Plasma Thromboplastic Factor A (Aggeler)

^*) T. P. C. Thromboplastic Plasma Component (Shinowara)

^*) Facteur Antihemophilique A (Soulier)

^*) Thromboplastinogen (Quick)

^*) Prothrombokinase (Feissly)

^*) Platelet Co-factor (Johnson)

^*) Plasmokinin ( Laki )

^*) Thrombokatalysin (Lenggenhager).

^**) Instituto de Investigaciones Hematologicas de la Academia Nacional de Medicina. Melo 3081. Buenos Aires. Argentina.

• References

• 1 Addis T. The pathogenesis of hereditary hemophilia. J. Path. Bact 1911; 15: 427
• 2 Aggeler P. M, White S. G, Glendening M. B, Page E. W, Leake T. B, Bates G. Plasma thromboplastin component (PTC). Proc. Soc. exp. Biol. (N.Y.) 1952; 79: 692
• 3 Alexander B. The clotting defect in Hemophilia (discussion). The hemophilia and hemophilioid diseases. Ed. Brinkhous; Chapel Hill: 1957: 22
• 4 Alexander B, Landwehr G. Studies of hemophilia II. The Assay of the antihemophilic clot-promoting principle in normal human plasma with some observation on the relative potency of certain plasma fraction. J. clin. Invest 1948; 27: 98
• 4a Andino P. A, Pavlovsky A. Tratamiento de la hemofilia. Symposium sobre Factor VIII. Acad. Nac. Med. Bs. As. Agosto. 1959
• 5 Bendien W. M, van Creveld S. Onderzoekinger over haemophilie. Maandschr. Kindergeneesk 1936; 5: 179
• 6 Bergna L. J, Pavlovsky A. Método para clasificar a los hemofílicos complicados por el desarrollo de un anticoagulante. Rev. Arg. de Hemat. y Hemoterapia 1955; 2: 138
• 7 Bergna L. J, Pavlovsky A. Valoración del factor Villi y IX en la hemofilia A y B. Symposium sobre el Factor VIII. Acad. Nac. Med. Bs. As. Agosto. 1959
• 7a Bergsagel D. E, Biggs R. The Christmas Factor. Rev. Hémat 1955; 10: 354
• 8 Bidwell E. The purification of bovine antihaemophilic Globulin. Brit. J. Haematol 1955; 1: 35
• 9 Biggs R, Douglas A. S. The thromboplastin generation test. J. clinfl Path 1953; 6: 23
• 10 Biggs R, Douglas A. S, Macfarlane R. G, Dacie J. V, Pitney W. R, Merskey C, O’Brien J. R. Christmas disease. Brit. med. Journ 1952; 2: 1378
• 11 Biggs R, Douglas A. S, Macfarlane R. G. The formation of thromboplastin in human blood. J. Physiol. (Lond.) 1953; 119: 89
• 12 Biggs R, Eveling S, Richards G. T. The assay of Antihemophilic activity. Brit. J. Haematol 1955; 1: 1
• 13 Biggs R, Macfarlane R. G. Haemophilia and related conditions. A Survey of 187 cases. Brit. J. Haematol 1958; 4: 1
• 14 Blombäck M. Studies on antihemophilic globulin. Acta Pediatrica, vol 1958; 47 supl 114
• 15 Bounameaux Y. Dosage des facteurs de coagulation contenus dans l’atmosphere plasmatique de plaquettes humaines. Rev. franc. del Et. Clin. et Biol 1957; 2: 52
• 16 Brakman P, van Creveld S, Engelsman E, vant Laar I. A, Mochtar I. A, Vender H. A. Deterioration of AHG (Factor VIII) and Fibrinolysis. Thromb. Diath. haem 1959; 3: 1
• 17 Brinkhous K. M. A study of the clotting defect in hemophilia: the delayed formation of thrombin. Amer. J. med. Sci 1939; 198: 509
• 18 Brinkhous K. M. Hemophilia. Bull. N.Y. Acad. Med 1954; 3: 325
• 19 Brinkhous K. M. Hemophilia and Hemophilioid Diseases (Int Symp.) Ed. K. M. Brinkhous; Chapel Hill: 1957
• 20 Brinkhous K. M, Penick G. D. Some Systemic alterations in clotting factors following local tissue Injury. Internat. Congr. on Thromb. and Embol. Basel: 1954: 428
• 21 Castex M. R, Paviovsky A. Hemophilic Sang. 1953; 24: 573
• 22 Castex M. R, Pavlovsky A, Simonetti C. Contribucion al estudio de la Fisiópatogenia de la hemofilia. Medicina 1944; 5: 16
• 23 Cohn E. J, Gurd F. R. N, Surgenor D. M, Barnes B. A, Brown R. K, Deronaux G, Gillespie J. M, Kahurt F. W, Lever W. F, Lin C. H, Mittelman D, Mouton R. F, Schmid R, Uroma E. A system for the separation of the components of human blood: Quantitative procedures for the separation of the protein components of human plasma. J. Amer. chem. Soc 1950; 72: 465
• 24 Cohn E. J, Strong L. E, Hughes W. L. S, Mulferd D. L, Ashworth J. N, Melir M, Taylor A. L. Preparation and properties of serum and plasma proteins. J. Amer. chem. Soc 1946; 68: 459
• 25 Cramer R, Flückiger P, Gasser C, Koller F, Loeliger A, Matter M. Hemophilia B. Acta haemat. (Basel) 1953; 10: 65
• 26 Deutsch E. Treatment of Surgical complications in hemophilia. Hemophilia and Hemophilioid Diseases. Ed. Brinkhous; Chapel Hill: 1957: 204
• 27 Fisch U, Duckert F. Some aspects of Kinetics of the first stages of blood thromboplastin formation. Thromb. Diath. haem 1959; 1: 98
• 28 Graham J. B. Biochemical Genetics of blood coagulation. Amer. J. hum. Genet 1956; 8: 63
• 29 Graham J. B, Bullock W. B, Barrow E. M. Genetic control of the hemophilioid states. Relat. VII Cong. Soc. Int. Hemat. Rome, Sept. 1958
• 29a Graham J. B, Barrow E. M. The pathogenesis of Hemophilia: An experimental analysis of the anticephalin hypothesis in hemophilic dogs. J. exp. Med 1957; 106: 273
• 30 Gross J. D, Hartmann R. C, Graham J. B, Bruce Taylor C. Splenectomy in Hemophilia. Bull. Johns Hopk. Hosp 1957; 100: 223
• 31 Hecht E. El problema de la hemofilia. Triangulo 1955; 2: 99
• 32 Hecht E. Sphingosine discovered as physiological inhibitor of blood clotting. Sixth Annual Symposium on Blood. Wayne State Univers. Detroit. 1957
• 33 Hougie C. The rol of factor V in the formation of blood thromboplastin. J. Lab. clin. Med 1957; 50: 61
• 34 Jacques L. B, Fisher L. M, Ashwin J. Platelet Serotonin as a factor in hemostasis. Int. Cong. on blood Transfusion. Roma, Sept. 1958
• 35 Jorpes E, Nilsson I. M, Blombäck M, Blombäck B. Correction with human plasma Fraction I—0 in Willebrands Disease. VII Congresso della Societá Inter-nazionale di Ematologia. Roma, Sept. 1958
• 36 Kekwick R. A, Mackay M. E. The separation of protein fractions from human plasma with ether. Spec. Rep. Serv. Med. Res. Coun. London: 286 1954
• 37 Kekwick R. A, Wolf P. A concentrate of Human antihaemophilic factor its use in six cases of haemophilia. Lancet 1957; 1: 647
• 37a Koller F, Krusse G, Lucksinger P. Über eine besondere Form hämor-rhagischer Diathese. Schweiz. med. Wschr 1950; 80: 41
• 38 Langdell R. D, Wagner R. H, Brinkhous K. M. Estimation of antihemophilic Activity by the Partial Thromboplastin Time Technic. The Coagulation of Blood, Ed. L. M. Tocantins; N. Y: 1955
• 39 Langdell R. D, Wagner R. H, Brinkhous K. M. Antihemophilic factor (AHF) levels following transfusion of blood plasma and plasma fractions. Proc. Soc. exp. Biol. (N. Y.) 1955; 88: 212
• 40 Lorand L, Laki K. A simple method for purifying an activator of prothrombin antihemophilic factor. Biochem. Biophys. Acta 1954; 13: 448
• 41 Lowenburg H, Rubenstone A. J. Hemophilia, experimental data bearing on the effect of glycerinized extracts of visceral hemophilic tissue on the coagulation time of blood. J. Amer. med. Ass 1918; 71: 1196
• 42 Macfarlane R. G, Biggs R, Bidwell E. Bovine antihemophilic globulin in the treatment of haemophilia. Lancet 1954; 1: 1313
• 43 Manteuffel Z. Bemerkungen zur Blutstillung bei Hämophilie. Dtsch. med. Wschr 1893; 19: 665
• 44 Margolis J. Plasma pain-producing substance and blood clotting. Nature (Lond.) 1957; b 180: 1464
• 45 Martinez Canaveri A, Pavlovsky A. Participación del Factor VIII en el proceso de la coagulatión. Symposium sobre el Factor VIII. Acad. Nac. Med. Bs. As. Agosto. 1959
• 46 Minot G. R, Davidson C. S, Lewis J. H, Tagnon H. J, Taylor F. H. L. The coagulation defect in Hemophilia: The effect in hemophilia of the parenteral administration of a fraction of the plasma globulins rich in fibrinogen. J. clin. Invest 1945; 24: 705
• 47 Nilsson I. M, Blombäck M, Jorpes E, Blombäck B, Johansson S. v. Willebrand’s Disease and its correction with Human plasma Fraction 1–0. Acta med. scand. vol. CLIX, Fasc. 1957: III
• 48 Owren P. A. The present state of the converting and accelerating factors in Prothrombin conversion. Internat. Conf. on Thromb. and Embol. Basel: 1954: 65
• 49 Patek A. J, Stetson R. P. The abnormal coagulation of the blood and its relation to the blood platelets. J. clin. Invest 1936; 15: 5
• 50 Patek A. J, Taylor F. H. L. Some properties of a substance obtained from human plasma effective in accelerating the coagulation of hemophilic blood. J. clin. Invest 1937; 16: 113
• 51 Pavlovsky A. Contribution to the Pathogenesis of Hemophilia. Blood 1947; 2: 185
• 52 Pavlovsky A. Present concepts of Hemophilia. Blood 1954; 9: 291
• 53 Pavlovsky A. Hemophilia. Pren. méd. argent 1958; 65: 2365
• 54 Pavlovsky A. Symposium on Hemophilia. VII Cong. Internat. Haemat. Roma, Sept. 1958
• 55 Pavlovsky A, Bergna L, Martinez Canaveri A. Thromboplastin in Hemophilia. Sang 1955; 26: 162
• 56 Pavlovsky A, Martinez Canaveri A, Andino Pavlovsky A. Emoterapia nella hemofilia. Relato al VII congreso de la Sociedad Internacional de Transfusión de sangre. Roma, Sept. 1958
• 57 Pavlovsky A, Martinez Canaveri A, Simonetti C, Arini E. Hemophilia. Comparative study of varieties of A and B. Report VI Congr. Int. Soc. Hem. Boston: 1956
• 58 Pavlovsky A, Mittelman D. G. de, Castellanos H. Interacción de plasma de distintos hemofilicos. Reunión Anual Ins. de Inv. Fis. aplic. a la Pat. Hum. Acad. Nac. Med. Bs. As. Dec. 1950
• 59 Pavlovsky A, Pavlovsky M. C. de. Female Haemophilia. Symposium on Hemophilia. VII congreso de la Soc. Int. de Hem. Roma, Sept. 1958
• 60 Pavlovsky A, Simonetti C. Determinación del poder coagulante de la fracción globulina extraída de plasmas hemofilicos. An. del Inst. Inv. Acad. Nac. Med 1944; 6: 341
• 61 Pavlovsky A, Simonetti C, Andino A. Hemofilia. Considerazioni sulla sua coagulazione. Relato VII Cong. de la Soc. Int. de Hemat. Roma: 1958
• 62 Penick G. D, Brinkhous K. M. Relative stability of plasma antihemophilic factor (AHF) under different conditions of storage. Am. J. med. Sci 1956; 232: 434
• 63 Pitney W. R. The assay of antikaemophilic globulin (AHG) in plasma. Brit. J. Haematol 1956; II: 3
• 64 Pool G. J, Robinson J. Assay of plasma antihemophilic globulin (AHG). Brit. J. Haematol 1959; 5: 17
• 65 Pool J. G, Spaet T. H. Ethionine induced depresion of plasma antihemophilic globulin in the rat. Proc. Soc. exp. Biol. (N. Y.) 1954; 87: 54
• 66 Quick A. J. The Hemorrhagic Diseases and the Physiology of Hemostasis. Charles C. Thomas; Springfield, Illinois: 1942
• 67 Quick A. J. Hemorrhagic Diseases. Lea and Febriger; Philadelphia: 1957
• 68 Quick A. J, Daniels E. R, Hussey C. V. Acquired antithromboplastino-genemia (Hemophilia-like disease) with special reference to its diagnosis. J. Lab. clin. Med 1954; 44: 94
• 69 Quick A. J, Stanley-Brown M, Bancroft F. W. A study of the coagulation defect in hemophilia and in jaundice. Amer. J. med. Sci 1935; 190: 501
• 70 Ratnoff O. D, Margolius A. International Symposium on Hemophilia and Hemophilioid Diseases. Ed. Brinkhous; Chapel Hill: 1957: p. 125
• 71 Schulman I. Management of Hemorrhage in hemophilia. Discussion. Hemophilia and Hemophilioid Diseases. Ed. K. M. Brinkhous; Chapel Hill: 1957: 215
• 72 Schulman I, Smith C. H. Hemorrhagic disease in an infant due to deficiency of a previously undescribed clotting factor. Blood 1952; 7: 794
• 73 Seegers W. H. Nature of the blood coagulation mechanisms. I. Inter. Conf. on Thromb. and Embol. 1954. Basel: 31
• 74 Seegers W. H, Landaburu R. H, Fenichel L. Isolation of platelet cofactor I from plasma and some properties of the preparation. Amer. J. Physiol 1957; 190: 1
• 75 Shinowara G. Y. Studies on the purification of Thromboplastic Plasma component (antihemophilic substance) in human blood. Amer. J. med. Sci 1957; 233: 5
• 76 Simonetti C, Casillas G, Pavlovsky A. Valoración de los metodos para purificar el factor VIII. Symposium sobre factor VIII. Acad. Nac. Med. Bs. As Agosto. 1959
• 77 Sjölin K. E. Classical Haemophilia (AHF deficiency) and Christmas Factor (PTC) deficiency as Simultaneous defects. Acta med. scand 1957; 159: 7
• 78 Sjölin K. E. A group of AHF deficient patients, corrected by adsorbed serum. Trans of the 6th. Congr. of the Europ. Soc. of Haemat. 1957: 164
• 79 Soulier J. P. Un nouvel adsorbant des facteurs de coagulation. La Bentonite. Rev. Hémat 1959; 14: 26
• 79a Soulier J. P. Standardization of So-called Antihemophilic Fractions. Hemophilia and Hemophilioid diseases. Ed. Brinkhous; Chapel Hill: 1957: 18
• 80 Soulier J. P, Gobbi F, et Larrieu M. J. Separation du Fibrinogene et du facteur antihemophilique A. Rev. Hématol 1957; 12: 481
• 81 Soulier J. P, Larrieu M. J. Nouvelle méthode de diagnostic de l’hemophilie: dosage des facteurs antihemophiliques A et B. Sang 1953; 24: 205
• 82 Soulier J. P, Wartelle O, Menachee D. Hageman Trait and PTA deficiency; the rol of contact of blood with glass. Brit. J. Haematol 1959; 5: 121
• 83 Spaet T. H, Aggeler P. M, Richards M. O. Prophylactic management of Hemophilia and PTC deficiency. Hemophilia and Hemophilioid diseases. Ed. Brink-hous; Chapel Hill: 1957: 11
• 84 Spaet T. H, Kinsell B. G. Properties of bovine antihemophilic factor. Proc. Soc. exp. Biol. (N. Y.) 1953; 84: 314
• 85 Taylor F. H. L, Davidson C. S, Tagnon H. J, Adams M. A, Mac-Donald A. H, Minot G. R. Studies in blood coagulation: the coagulation properties of certain globulin fractions of normal human plasma “in vitro”. J. clin. Invest 1945; 24: 698
• 85a Tocantins L. M, Caroll R. T, Holburn R. H. The clot accelerating effect of dilution on blood and plasma; relation to the mechanism of coagulation of normal and hemophilic blood. Blood 1951; 6: 720
• 86 Verstraete M. De Vorming van Plasma Thromboplastine — Arscia Uitgaven Stoofsträat 60. Brussel: 1955
• 87 Verstraete M, Vandenbroucke J. Combined antihemophilic Globulin and Christmas factor deficiency in haemophilia. Brit. Med. J 1955; 11: 1533
• 88 Wagner R. H, Thelin Murray G. Antihemophilic Factor: Current Status of Purification Chemical and Physical characterization. Hemophilia and Hemophilioid Diseases. Ed; Brinkhous Chapel Hill: 1957: 3
• 89 Winterstein A, Marbet R, Strassle R. Isolation, Stability and assay of Antihemophilic globulin. Hemophilia and Hemophilioid Diseases. Ed; Brinkhous, Chapel Hill: 1957: 11
• 90 Wolf P. Studies of Temperature and pH stability of Human antihaemophilic Factor (AHF) in plasma and in a concentrate. Brit. J. Haematol 1959; 5: 169